Skip to main content

Lloyd Harvey MD, PhD

    Education & Training

  • University of Pittsburgh, BS, 2015
Representative Publications

Harvey LD, Chan SY. Evolving systems biology approaches to understanding non-coding RNAs in pulmonary hypertension. J Physiol. 2018. PubMed PMID: 30113078.

Harvey LD, Chan SY. YAPping About Glutaminolysis in Hepatic Fibrosis. Gastroenterology. 2018;154(5):1231-1233.

Ranchoux B, Harvey LD, Ayon RJ, et al. Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045893217752912. PubMed PMID: 29283043; PubMed Central PMCID: PMC5798691.

Harvey LD, Chan SY. Emerging Metabolic Therapies in Pulmonary Arterial Hypertension. J Clin Med. 2017;6(4). PubMed PMID: 28375184; PubMed Central PMCID: N/A.

Begum G*, Harvey L*, Dixon CE, Sun D. ER stress and effects of DHA as an ER stress inhibitor. Translational Stroke Research. 2013;4(6):635-42. Epub 2013/12/11. doi: 10.1007/s12975-013-0282-1. PubMed PMID: 24323417; PubMed Central PMCID: PMC3864671. *denotes co-first authorship.

Harvey L, Yin Y, Attarwala IY, Begum G, Deng J, Yan HQ, Dixon CE, Sun D. Administration of DHA reduces ER stress-associated inflammation and alters microglial or macrophage activation in traumatic brain injury. ASN Neuro. 2015;7(6). PubMed PMID: 26685193; PubMed Central PMCID: PMC4710127.

Zonouzi M, Scafidi J, Li P, McEllin B, Edwards J, Dupree JL, Harvey L, Sun D, Hubner CA, Cull-Candy SG, Farrant M, Gallo V. GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury. Nature Neuroscience. 2015;18(5):674-82. Epub 2015/03/31. doi: 10.1038/nn.3990. PubMed PMID: 25821912; PubMed Central PMCID: PMC4459267.

Career Advisor
Donald DeFranco, PhD
Thesis Advisor
Stephen Chan, MD, PhD
Molecular Pharmacology
Dissertation Title

NCOA7 deficiency reprograms lysosomal behavior and sterol metabolism to promote endothelial dysfunction and pulmonary arterial hypertension

Graduate Year
Training Start Year